SYNDEXA PHARMACEUTICALS

Syndexa Pharmaceuticals Corp., a Watertown, MA-based biopharmaceutical company developing drugs to treat metabolic diseases. Founded by scientists from Harvard University, and led by President and CEO Teo Uysal, Syndexa is dedicated to the discovery and development of a new generation of small-molecule drugs targeting novel mechanisms for the treatment and prevention of diseases of endoplasmic reticulum (ER) dysfunction which include inflammatory and metabolic diseases and disorders, cardiovascular diseases and neurodegenerative diseases. The company has raised $24.8m of equity capital to date.

#People #Financial #Website #More

SYNDEXA PHARMACEUTICALS

Industry:

Biopharma Biotechnology Pharmaceutical

Founded:

2005-01-01

Address:

Watertown, Massachusetts, United States

Country:

United States

Website Url:

http://www.syndexa.com

Total Employee:

11+

Status:

Closed

Contact:

617-607-7283

Email Addresses:

[email protected]

Total Funding:

23.5 M USD

Technology used in webpage:

SPF SEDO DNS

Current Employees Featured

teo-uysal_image

Teo Uysal
Teo Uysal Founder, President and CEO @ Syndexa Pharmaceuticals
Founder, President and CEO

Founder

teo-uysal_image

Teo Uysal

Investors List

mp-healthcare-venture-management-inc_image

MP Healthcare Venture Management

MP Healthcare Venture Management investment in Series B - Syndexa Pharmaceuticals

yalcin-ayasli_image

Yalcin Ayasli

Yalcin Ayasli investment in Series B - Syndexa Pharmaceuticals

Official Site Inspections

http://www.syndexa.com

Host Informations
Whois Informations

Loading ...

More informations about "Syndexa Pharmaceuticals" on Search Engine